All Stories

  1. N-alkylated Tacrine Derivatives as Potential Agents in Alzheimer’s Disease Therapy

    Article • Current Alzheimer Research, April 2019, Bentham Science Publishers

    Jan Korabecny, Rafael Dolezal

  2. In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2019, Taylor & Francis

    Jan Korabecny

  3. A Review of the Synthesis of Quaternary Acetylcholinesterase Reactivators

    Article • Current Organic Chemistry, September 2018, Bentham Science Publishers

    Jan Korabecny, Rafael Dolezal

  4. Purin-6-one and pyrrolo[2,3-d]pyrimidin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity

    Article • Future Medicinal Chemistry, August 2018, Future Science

    Jan Korabecny

  5. In vitro and in silico Evaluation of Non-Quaternary Reactivators of AChE as Antidotes of Organophosphorus Poisoning - a New Hope or a Blind Alley?

    Article • Medicinal Chemistry, April 2018, Bentham Science Publishers

    Jan Korabecny, Rafael Dolezal

  6. Profiling donepezil template into multipotent hybrids with antioxidant properties

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2018, Taylor & Francis

    Jan Korabecny, Rafael Dolezal

  7. Progress in acetylcholinesterase reactivators and in the treatment of organophosphorus intoxication: a patent review (2006–2016)

    Article • Expert Opinion on Therapeutic Patents, June 2017, Taylor & Francis

    Jan Korabecny, Rafael Dolezal